NCT03950817View on ClinicalTrials.gov

Nebulized Sub-dissociative Dose Ketamine at Three Different Dosing Regimens for Treating Acute Pain in the Pediatric ED

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 13, 2019

Primary Completion Date

September 24, 2024

Study Completion Date

September 24, 2024

Conditions
Pain
Interventions
DRUG

Nebulized Sub-dissociative Dose Ketamine at either 0.75 mg/kg

Nebulized Sub-dissociative Dose Ketamine at 0.75 mg/kg

DRUG

Nebulized Sub-dissociative Dose Ketamine at 1 mg/kg

Nebulized Sub-dissociative Dose Ketamine at either 0.75 mg/kg, 1 mg/kg, and 1.5 mg/kg.

DRUG

Nebulized Sub-dissociative Dose Ketamine at 1.5 mg/kg.

Nebulized Sub-dissociative Dose Ketamine at 1.5 mg/kg.

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

All Listed Sponsors
lead

Antonios Likourezos

OTHER

NCT03950817 - Nebulized Sub-dissociative Dose Ketamine at Three Different Dosing Regimens for Treating Acute Pain in the Pediatric ED | Biotech Hunter | Biotech Hunter